Cell & Gene Therapy

Exploring the latest news and insight around cell and gene therapy, including new technology and information on treatments. See how pharma is leveraging gene therapy and cell therapy to prevent and treat disease.

Orca
Pharma

Orca Bio takes commercial leap with FDA approval for Tregzi

Orca Bio is charging the WAC of $428,000 for Tregzi, a novel regulatory T cell-based therapy for blood cancer patients requiring transplants.
Angus Liu Jul 1, 2026 12:14am
Bubbles in boiling water
Favicon Fierce Biotech

Big Pharma-backed SonoThera sounds off with $125M series B

Jun 10, 2026 10:48am
two arrows pointing different directions

FDA to reconsider rejected cell therapy. Could uniQure be next?

May 7, 2026 10:40am
Trust in block letters

Bayer diagnoses how to build trust in cell and gene therapies

May 6, 2026 10:45am
Asia

Sun-Organon, Astellas, BeOne—Fierce Pharma Asia

May 1, 2026 8:43am
hearing audio waves

Regeneron ushers in new era with inaugural gene therapy approval

Apr 23, 2026 3:22pm